Lack of effect of renal function on uptake of 99mTc-sestamibi in renal masses
However, further research with larger sample sizes is required to validate and generalize these findings. Ultimately, understanding the broad variety of applicability of 99m Tc-sestamibi uptake for risk stratification of renal malignancy could aid in appropriate clinical decision-making.
Authors
- Benjamin L. Viglianti (ORCID: https://orcid.org/0000-0002-8471-4988)
- Basil Kaufmann (ORCID: https://orcid.org/0000-0001-6965-449X)
- Lilja B. Sólnes (ORCID: https://orcid.org/0000-0002-2192-7425)
- Thad Benefield (ORCID: https://orcid.org/0000-0002-4218-3330)
- Nirmish Singla (ORCID: https://orcid.org/0000-0001-9495-6983)
- Anas Al Zubaidi (ORCID: https://orcid.org/0000-0001-8234-9801)
- S. Osman (ORCID: https://orcid.org/0009-0008-0252-2028)
- Sara Sheikhbahaei (ORCID: https://orcid.org/0000-0001-7866-4681)
- Adham Khalil (ORCID: https://orcid.org/0000-0002-0582-8160)
- Jorge D. Oldan (ORCID: https://orcid.org/0000-0002-8979-2010)
- Steven P. Rowe (ORCID: https://orcid.org/0000-0003-2897-4694)
- Christian P. Pavlovich (ORCID: https://orcid.org/0000-0002-8532-0251)
- Michael A. Gorin (ORCID: https://orcid.org/0000-0002-8315-6603)
- Salikh Murtazaliev
- Alireza Amindarolzarbi (ORCID: https://orcid.org/0000-0002-3029-3188)
- Kendall Satcowitz
Institutions
- University of North Carolina at Chapel Hill (US)
- Johns Hopkins University (US)
- American Urological Association (US)
- University of Michigan (US)
- Johns Hopkins Medicine (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Nuclear Medicine Communications
- Published
- 2025-01-29
- DOI
- https://doi.org/10.1097/mnm.0000000000001960
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00